{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-pneumococcal/background-information/pneumococcal-immunization/","result":{"pageContext":{"chapter":{"id":"492f20c5-5e03-51dc-9ccb-1994f3db1c35","slug":"pneumococcal-immunization","fullItemName":"Pneumococcal immunization","depth":2,"htmlHeader":"<!-- begin field 6260d44e-d119-4aa5-af49-8a69b831a441 --><h2>Pneumococcal immunization</h2><!-- end field 6260d44e-d119-4aa5-af49-8a69b831a441 -->","summary":"","htmlStringContent":"<!-- begin item 510b4dfa-a7a1-4b12-a73f-3482cb205e14 --><!-- begin field 745bf8a4-6356-46f8-9ee2-a55920ee9370 --><ul><li><strong>Pneumococcal vaccines</strong> use purified capsular polysaccharide from several strains of <em>Streptococcus pneumoniae</em> to achieve active immunity.<ul><li>The primary response occurs after the first administration of vaccine to a person without prior exposure to the antigen. A slow antibody response (predominantly immunoglobulin M) is produced.</li><li>The secondary response occurs when further administrations increase the antibody titre (predominantly immunoglobulin G).</li><li>Most adults will have had some previous exposure to <em>S. pneumoniae</em>, and so will develop a good immunoglobulin G antibody response to a single dose of pneumococcal vaccine by the third week following immunization.</li><li>Infants (children under 12 months), however, need a primary series of two injections to produce immunity.</li></ul></li><li><strong>There are two types of pneumococcal vaccine available in the UK:</strong><ul><li><strong>Prevenar 13</strong><sup>®</sup> is a 13-valent pneumococcal conjugate vaccine (PCV13) mainly suitable for children aged less than 2 years as part of the Childhood Immunization Programme, or for children aged less than 5 years considered to be at <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/background-information/risk-factors-for-pneumococcal-disease/\">high risk of infection</a>.<ul><li>Conjugating the capsular polysaccharide to other proteins improves the immunogenicity of the vaccine in younger children.</li><li>Pneumococcal conjugate vaccines protect against pneumococcal meningitis, bacteraemia, pneumonia, and otitis media [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">Bernatoniene and Finn, 2005</a>].</li><li>There is also evidence that pneumococcal conjugate vaccines provide 'herd immunity' by decreasing nasal carriage of <em>S. pneumoniae</em>, and reduce the incidence of penicillin-resistant pneumococci [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">Bernatoniene and Finn, 2005</a>].</li></ul></li><li><strong>Pneumovax<sup>®</sup></strong> is a 23-valent pneumococcal polysaccharide vaccine (PPV23), suitable for older children (aged 2 years and over) and adults.<ul><li>The 23 capsular types contained within the vaccine account for about 96% of the isolates that cause pneumococcal disease in the UK.</li><li>The overall effectiveness is difficult to estimate, but vaccination probably prevents about 50–70% of cases of pneumococcal bacteraemia.</li><li>The vaccine is probably ineffective at preventing non-bacteraemic pneumococcal pneumonia, otitis media, or exacerbations of chronic bronchitis.</li><li>There is no evidence for its effectiveness in children under 2 years of age.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-pneumococcal/references/\">PHE, 2013a</a>]</p><!-- end field 745bf8a4-6356-46f8-9ee2-a55920ee9370 --><!-- end item 510b4dfa-a7a1-4b12-a73f-3482cb205e14 -->","topic":{"id":"af89c4a4-b7c5-5032-9cab-157c542f213b","topicId":"667146c4-e374-494f-a050-b8976e5e7056","topicName":"Immunizations - pneumococcal","slug":"immunizations-pneumococcal","lastRevised":"Last revised in January 2021","chapters":[{"id":"c2a8d969-5d35-5185-b666-883786b066c5","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9db009c1-59ed-5d79-9446-33e54e1676c7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"cf4adec7-88ef-5a0f-b072-53bd3049b260","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5459dd7c-ac40-5828-8bec-840fa7fca764","slug":"changes","fullItemName":"Changes"},{"id":"197178ce-11cd-52df-883c-419e06744dd4","slug":"update","fullItemName":"Update"}]},{"id":"95a44f6b-2987-5086-8656-ef21fcbbc28b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"006db835-5d01-5085-a6e1-ee57f7ca41c8","slug":"goals","fullItemName":"Goals"},{"id":"29af8dc8-13e9-56c4-a041-b00bbf320b1e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e7b32647-3434-5f3f-b8be-51203e3ebfee","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ebc71bdc-4766-5946-bb16-121b9da544f3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3daf6a12-bce0-53d4-a318-05cc49aab107","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"4dce4bc5-1119-5c5d-9422-d275fc956a4e","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"37c59838-49d0-51d5-8203-1eae848738c2","slug":"definition-of-pneumococcal-disease","fullItemName":"Definition of pneumococcal disease"},{"id":"aba9a3c5-f0f7-5e65-b369-1947461d0158","slug":"prevalence-of-pneumococcal-disease","fullItemName":"Prevalence of pneumococcal disease"},{"id":"9da9e662-ccc4-5bc4-bae8-eb3f0ec80b19","slug":"risk-factors-for-pneumococcal-disease","fullItemName":"Risk Factors for pneumococcal disease"},{"id":"492f20c5-5e03-51dc-9ccb-1994f3db1c35","slug":"pneumococcal-immunization","fullItemName":"Pneumococcal immunization"}]},{"id":"e183f01f-d538-542b-bc16-6f849966d1d2","fullItemName":"Management","slug":"management","subChapters":[{"id":"b036915e-0e64-5fea-a247-9777822304b3","slug":"routine-vaccination-of-infants-adults-over-65-years-of-age","fullItemName":"Scenario: Routine vaccination of infants, and adults over 65 years of age"},{"id":"8f83b7e0-d764-5bca-a03b-e549e24f402a","slug":"children-diagnosed-at-increased-risk-under-2-years-of-age","fullItemName":"Scenario: Children diagnosed at increased risk under 2 years of age"},{"id":"c9787edf-835f-54d9-9b86-b7c8695307ef","slug":"children-diagnosed-at-increased-risk-aged-2-5-years","fullItemName":"Scenario: Children diagnosed at increased risk aged 2-5 years"},{"id":"7f443a07-5081-5296-b56e-8b82550f8c52","slug":"children-over-5-years-of-age-adults-diagnosed-at-increased-risk","fullItemName":"Scenario: Children over 5 years of age and adults diagnosed at increased risk"}]},{"id":"f17e101b-7bea-59aa-9b9c-46924bbfdc2b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"871f5861-588e-57ef-9521-0a81e77d4583","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"d0a50959-6448-5a18-8845-f75f5c40f388","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"92b33782-e97b-565d-b432-b19376ecedbc","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5b1e27f9-71f0-5238-978b-5648b601e292","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"2b6c5d09-7606-5742-89c4-19fa3b671fd7","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"037af05f-e510-5862-b316-4676f7c3a61e","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"04bd9328-ed11-5b9d-ba9a-06584ecd6f33","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"002fbb60-3041-597d-9d3d-fc3a17068591","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}